# EDGAR Filing Document

**Accession Number:** 0002045356
**File Stem:** 0002045356-26-000003
**Filing Date:** 2026-5
**Character Count:** 2895
**Document Hash:** def5ab2d7a4bb9e30f7482063d358c28
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002045356-26-000003.hdr.sgml**: 20260501

**ACCESSION NUMBER**: 0002045356-26-000003

**CONFORMED SUBMISSION TYPE**: C-AR

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260501

**DATE AS OF CHANGE**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Ignite Biomedical, Inc.
- **CENTRAL INDEX KEY:** 0002045356

**ORGANIZATION NAME:**
- **EIN:** 921047173
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-AR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-35542
- **FILM NUMBER:** 26928380

**BUSINESS ADDRESS:**
- **STREET 1:** 945 CONCORD STREET, SUITE 202
- **CITY:** FRAMINGHAM
- **STATE:** MA
- **ZIP:** 01701
- **BUSINESS PHONE:** (617) 529-6312

**MAIL ADDRESS:**
- **STREET 1:** 945 CONCORD STREET, SUITE 202
- **CITY:** FRAMINGHAM
- **STATE:** MA
- **ZIP:** 01701

### Attached PDF Documents

**Attachment 1:** `form_car.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** Ignite Biomedical, Inc.

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 11-02-2022

**Physical Address:** 945 Concord Street, Suite 202, Framingham, MA, 01701

**Issuer Website:** https://www.ignitebiomedical.com/

**Is there a Co-Issuer?:** No

### Annual Report Disclosure Requirements

**Current Number of Employees:** 2

**Total Assets (Most Recent Fiscal Year):** $1,223,102.00

**Total Assets (Prior Fiscal Year):** $1,233,658.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $223,102.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $233,657.00

**Accounts Receivable (Most Recent Fiscal Year):** $0.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $6,999.00

**Short-Term Debt (Prior Fiscal Year):** $3,808.00

**Long-Term Debt (Most Recent Fiscal Year):** $2,996,400.00

**Long-Term Debt (Prior Fiscal Year):** $0.00

**Revenues/Sales (Most Recent Fiscal Year):** $0.00

**Revenues/Sales (Prior Fiscal Year):** $0.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $0.00

**Cost of Goods Sold (Prior Fiscal Year):** $0.00

**Taxes Paid (Most Recent Fiscal Year):** $456.00

**Taxes Paid (Prior Fiscal Year):** $456.00

**Net Income (Most Recent Fiscal Year):** $-2,103,505.00

**Net Income (Prior Fiscal Year):** $-517,884.00

### Signatures

**Issuer:** Ignite Biomedical, Inc.

**Signature:** Claudio Faira

**Title:** CEO and Chairman of the Board

---

**Signature:** Claudio Faira

**Title:** CEO and Chairman of the Board

**Date:** 04-30-2026

---

**Signature:** Jake Nichols

**Title:** CMO and Secretary of the Board

**Date:** 04-30-2026